[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.147.69. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
October 20, 1999

Cost-effectiveness of Methods to Enhance Sensitivity of Papanicolaou Testing

Author Affiliations
 

Margaret A.WinkerMD, Deputy EditorIndividualAuthorPhil B.FontanarosaMD, Interim CoeditorIndividualAuthor

JAMA. 1999;282(15):1419-1420. doi:10-1001/pubs.JAMA-ISSN-0098-7484-282-15-jac90009

To the Editor: The article by Mr Brown and Dr Garber1 contributes little to our understanding of important issues relating to improved methods of screening for cervical cancer. It relies on fundamentally unsound assumptions.

The Eddy model on which this study was based was designed to study screening intervals, not cost-effectiveness. This flawed model was constructed on an old database, which does not reflect the impact of the human papillomavirus epidemic and did not screen patients younger than 35 years.2 Since cervical cancer has become such a rare disease, measuring changes in life-years saved is not relevant.

First Page Preview View Large
First page PDF preview
First page PDF preview
×